ライフサイエンスコーパス: enzyme-linked immunospot assay

1 response to HCV antigens were enumerated by Enzyme Linked Immunospot Assay.

2 producing B cells could still be detected by enzyme-linked immunospot assay.

3 us peptides via interferon-gamma (IFN-gamma) enzyme-linked immunospot assay.

4 5, 7, and 14 postgrafting, as measured by an enzyme-linked immunospot assay.

5 +) T lymphocytes were induced as analyzed by enzyme-linked immunospot assay.

6 h nodes, lungs, and Peyer's patches using an enzyme-linked immunospot assay.

7 -positive, HLA A2-positive individuals in an enzyme-linked immunospot assay.

8 pond to HIV-1 peptides in a gamma interferon enzyme-linked immunospot assay.

9 T-cell responses by using a gamma interferon enzyme-linked immunospot assay.

10 ed in the various tissues of GalT-/- mice by enzyme-linked immunospot assay.

11 mic lymphoid tissues were evaluated using an enzyme-linked immunospot assay.

12 red in peripheral blood mononuclear cells by enzyme-linked immunospot assay.

13 -seropositive individual using the IFN-gamma enzyme-linked immunospot assay.

14 ction in tear IgA induction, was measured by enzyme-linked immunospot assay.

15 t assay and lung antibody secreting cells by enzyme-linked immunospot assay.

16 sponses were assessed using an ex-vivo IFN-y enzyme-linked immunospot assay.

17 body assay, and an interferon gamma-specific enzyme-linked immunospot assay.

18 body- forming cells were determined using an enzyme-linked immunospot assay.

19 cells measured before challenge by cultured enzyme-linked immunospot assay.

20 ses were assessed using an ex-vivo IFN-gamma enzyme-linked immunospot assay.

21 and dsDNA antibody-secreting cells (ASCs) by enzyme-linked immunospot assay.

22 ral suppression assay (VSA) and an IFN-gamma enzyme-linked immunospot assay.

23 red by enzyme-linked immunosorbent assay and enzyme-linked immunospot assay.

24 s were detected by gamma interferon-specific enzyme-linked immunospot assay.

25 e assessed using an ex-vivo interferon-gamma enzyme-linked immunospot assay.

26 B cell Ig isotype switching was measured by enzyme-linked immunospot assay.

27 tibody-secreting cells were enumerated using enzyme-linked immunospot assay.

28 assays, intracelluar cytokine staining, and enzyme-linked immunospot assay.

29 l responses were assayed by interferon-gamma enzyme-linked immunospot assay.

30 ymphocyte proliferation and interferon gamma enzyme-linked immunospot assay.

31 racheobronchial lymph nodes as determined by enzyme-linked immunospot assay.

32 and in 22 (73%) of 30 vaccine recipients by enzyme-linked immunospot assay.

33 emory responses were evaluated by IFN- gamma enzyme-linked immunospot assay.

34 ulated memory B cells were detected using an enzyme-linked immunospot assay.

35 , and IL-6 cytokines as measured by cytokine enzyme-linked immunospot assay.

36 producing gamma interferon when analyzed by enzyme-linked immunospot assay.

37 d mononuclear cells using flow cytometry and enzyme-linked immunospot assays.

38 T-cell responses as measured using IFN-gamma enzyme-linked immunospot assays.

39 DNA cells by IFN-gamma-secretion measured in enzyme-linked immunospot assays.

40 ls in both cytotoxicity assays and IFN-gamma enzyme-linked immunospot assays.

41 the lamina propria of the small intestine by enzyme-linked immunospot assays.

42 aining, and fine mapping in interferon-gamma enzyme-linked immunospot assays.

43 lected at selected times were quantitated by enzyme-linked immunospot assays.

44 (spleen and blood) lymphoid tissues by using enzyme-linked immunospot assays.

45 with baseline values (day 0), measured using enzyme-linked immunospot assays.

46 cell responses, measured by interferon gamma enzyme-linked immunospot assays.

47 wild-type sequence was also demonstrated by enzyme-linked immunospot assays.

48 A-matched peptides by using gamma interferon enzyme-linked immunospot assays.

49 pol regimen, as measured by gamma interferon enzyme-linked immunospot assays.

50 ysis), and more IFN-gamma-secreting cells by enzyme-linked immunospot assay (1460 vs 280 IFN-gamma sp

51 ted in these animals by the gamma interferon enzyme-linked immunospot assay against pools of short ov

52 specific CD8+ CTL responses were detected by enzyme-linked immunospot assay against several NY-BR-1 p

53 mune responses were measured by tetramer and enzyme-linked immunospot assays against gp100 and MART-1

54 lobulin M antibody-secreting cells (ASCs) by enzyme-linked immunospot assay allowed for differentiati

55 e compared by standardized interferon- gamma enzyme-linked immunospot assays among 250 unvaccinated i

56 Cultured enzyme-linked immunospot assay analysis demonstrated tha

57 lar sensitization was detected by performing enzyme-linked immunospot assay analysis for cytokines in

58 ce data of specific genes were combined with enzyme-linked immunospot assay analysis of critical epit

59 Enzyme-linked immunospot assay analysis of peripheral T-

60 rus-specific T-cell responses by means of an enzyme-linked immunospot assay and antibody responses by

61 A antibody-secreting B cells was analyzed by enzyme-linked immunospot assay and by analysis of Epstei

62 Enzyme-linked immunospot assay and ELISA analysis were r

63 (+) T cells, as detected by interferon gamma enzyme-linked immunospot assay and flow cytometry, were

64 he vaccine and drifted A(H3N2) viruses by an enzyme-linked immunospot assay and flow cytometry.

65 By gamma interferon enzyme-linked immunospot assay and intracellular cytokin

66 ion assay) and T cell responses (measured by enzyme-linked immunospot assay and intracellular cytokin

67 Using two sensitive assays (enzyme-linked immunospot assay and intracellular stain)

68 ain SCC-derived antigens using the IFN-gamma enzyme-linked immunospot assay and intratumor (IT) and c

69 at multiple time points by interferon-gamma enzyme-linked immunospot assay and was correlated to the

70 this limitation by using two-color cytokine enzyme-linked immunospot assays and computer-assisted im

71 or cell readout assays (such as the cytokine enzyme-linked immunospot assay) and MS to identify relev

72 mined by intracellular cytokine staining and enzyme-linked immunospot assay) and produced anti-PR8 an

73 ss I Gag-tetramer staining, gamma interferon-enzyme-linked immunospot assay, and cytotoxic T-cell ass

74 ays, antigen-specific interferon (IFN)-gamma enzyme-linked immunospot assay, and enzyme-linked immuno

75 ern blot, delayed type hypersensitivity, and enzyme-linked immunospot assay, and reduced the number o

76 tified memory responses measured by cultured enzyme-linked immunospot assay as well as in vitro inter

77 e measured in 9 patients by interferon-gamma enzyme-linked immunospot assay at 3 time points within 1

78 in the blood by gamma interferon (IFN-gamma) enzyme-linked immunospot assay at select time points; ho

79 re likely to have a positive response to ASC enzyme-linked immunospot assay at the late time point th

80 T-cell responses were analyzed using T-cell enzyme-linked immunospot assay before convalescent plasm

81 a virus were detected by an interferon gamma enzyme-linked immunospot assay but had no clear relation

82 analyzed in the gamma interferon (IFN-gamma)-enzyme-linked immunospot assay by using synthetic overla

83 f CNS-derived mononuclear cells by IFN-gamma enzyme-linked immunospot assay confirmed the selection o

84 An Ag-specific B cell enzyme-linked immunospot assay confirmed these results a

85 Enzyme-linked immunospot assays confirmed this high freq

86 d multiparameter flow cytometric sorting and enzyme-linked immunospot assay, demonstrate that anti-Ga

87 FITC/DNFB skin painting and subsequent enzyme-linked immunospot assay demonstrated that flow-so

88 s from MAN and/or MPL-treated mice, using an enzyme-linked immunospot assay designed to detect indivi

89 1 subject, antigen-specific interferon-gamma enzyme-linked immunospot assay detected an immunogenic d

90 Enzyme-linked immunospot assays detected precursor CTL s

91 Viral loads, CD4(+) T-cell counts, and enzyme-linked immunospot assay-determined anti-HIV-1 CD8

92 ific T cells, enumerated by gamma interferon enzyme-linked immunospot assay, did not appear until 2 w

93 ls developed neutralizing antibodies and low enzyme-linked immunospot assay (E-SPOT) titers against S

94 Enzyme-linked immunospot assay (ELISPOT) analysis of pso

95 ssed by ex vivo gamma interferon (IFN-gamma) enzyme-linked immunospot assay (ELISPOT) and antibody as

96 LSA-1 and TRAP peptides were assessed by the enzyme-linked immunospot assay (ELISPOT) and enzyme-link

97 to detect autoreactive responses when using enzyme-linked immunospot assay (ELISPOT) and enzyme-link

98 une responses were measured by ex-vivo IFN-y enzyme-linked immunospot assay (ELISpot) and T-cell prol

99 ere detected by interferon-gamma (IFN-gamma) enzyme-linked immunospot assay (ELISPOT) assays using th

100 Gamma interferon (IFN-gamma) measured by enzyme-linked immunospot assay (ELISPOT) at multiple tim

101 racellular IFN-gamma staining, and IFN-gamma enzyme-linked immunospot assay (ELISPOT) indicated that

102 We used flow cytometry and enzyme-linked immunospot assay (ELISPOT) to examine B-ce

103 We used the ex vivo IFN-gamma enzyme-linked immunospot assay (ELISpot) to track T cell

104 antigen-specific IFN-gamma production in an enzyme-linked immunospot assay (ELISPOT).

105 after allogeneic BMT using gamma-interferon enzyme-linked immunospot assay (ELISPOT).

106 ent assays (ELISA) titers, and EnvA-specific enzyme-linked immunospot assays (ELISPOT) responses.

107 tion, and measured antibody-secreting cells (enzyme-linked immunospot assay [ELISPOT]) as an early ma

108 phisms with cellular (interferon [IFN] gamma enzyme-linked immunospot assay [ELISPOT]) immune respons

109 in humans before transplantation, we used an enzyme-linked immunospot assay for detection of allospec

110 e further confirmed by the results of CD4(+) enzyme-linked immunospot assay for interferon (IFN)-gamm

111 ng was performed using a CEA peptide and the enzyme-linked immunospot assay for interferon gamma prod

112 Spleen cells were phenotyped, and enzyme-linked immunospot assays for autoantibody-produci

113 cluding MHC class I tetramer binding assays, enzyme-linked immunospot assays for IFN-gamma production

114 cells that recognize EBV-latent antigens in enzyme-linked immunospot assays for interferon gamma sec

115 BL/6 beta-gal transgenic skin were tested in enzyme-linked immunospot assays for recall responses to

116 When experiments were performed by the enzyme-linked immunospot assay, high numbers of cells pr

117 us cytokine production by MLN cells using an enzyme-linked immunospot assay, immunohistochemistry, an

118 ntified T-cell responses by interferon-gamma enzyme-linked immunospot assay in all participants where

119 quantified T-cell responses by interferon-y enzyme-linked immunospot assay in all participants where

120 , and GAD65 peptides) were measured by IL-17 enzyme-linked immunospot assay in patients with new-onse

121 berculosis strain H37Rv as a stimulant in an enzyme-linked immunospot assay in sensitized individuals

122 ), and in healthy control subjects (n=10) by enzyme-linked immunospot assay in the presence and absen

123 c CD8(+)-T-cell responses were determined by enzyme-linked immunospot assays in 150 HIV-infected indi

124 ti-Gal-producing B cells was demonstrated by enzyme-linked immunospot assays in mixed KO + WT --> KO

125 s shown by cytotoxicity and interferon gamma enzyme-linked immunospot assays in six of nine patients.

126 Both 51Cr release assays and IFN-gamma enzyme-linked immunospot assays indicated that IFN-gamma

127 ength of the allospecific immune response by enzyme-linked immunospot assay may allow improved pairin

128 immune-sensitization using the B and T-cell enzyme-linked immunospot assays may identify CMV-sensiti

129 eins were used to screen 15 normal donors in enzyme-linked immunospot assays of gamma interferon rele

130 pping peptides and gamma interferon-specific enzyme-linked immunospot assays of peripheral blood mono

131 Results of enzyme-linked immunospot assays of the immunized mice re

132 Interferon-gamma (IFN-gamma) enzyme-linked immunospot assays on peripheral blood mono

133 were assessed using interferon (IFN)- gamma enzyme-linked immunospot assays on peripheral blood mono

134 validation cohort were measured by IFN-gamma enzyme-linked immunospot assay or intracellular cytokine

135 nterferon (IFN)-gamma and interleukin (IL)-5 enzyme-linked immunospot assays, respectively.

136 production in mixed lymphocyte reaction and enzyme-linked immunospot assays, respectively.

137 ed a 10- to 40-fold increase in HIV-specific enzyme-linked immunospot assay responses compared to tho

138 mmunosorbent assay titers, and EnvA-specific enzyme-linked immunospot assay responses, and these resp

139 Enzyme-linked immunospot assay results indicated that th

140 s of Candida-specific T-cell responses using enzyme-linked immunospot assays revealed higher numbers

141 IFN-gamma enzyme-linked immunospot assay showed that the D2V (71-7

142 mmunity to SHIV89.6 peptides was measured by enzyme-linked immunospot assay; strong responses to Gag

143 y higher numbers of spot-forming cells in an enzyme-linked immunospot assay than did T cells primed w

144 y-secreting cells (ASC) in blood measured by enzyme-linked immunospot assay, the antibody in lymphocy

145 By use of enzyme-linked immunospot assays, the percentages of memo

146 s, trans-vivo delayed-type hypersensitivity, enzyme-linked immunospot assays, the use of antigen rece

147 t gamma interferon production, determined by enzyme-linked immunospot assay to at least one of the th

148 To address this, we used an enzyme-linked immunospot assay to define the frequency a

149 We used an enzyme-linked immunospot assay to determine the frequenc

150 1 transgenic NOD mice in an interferon-gamma enzyme-linked immunospot assay to identify autoantigenic

151 D8 T cell responses were quantified using an enzyme-linked immunospot assay to measure interferon-gam

152 MI responses by interferon gamma (IFN-gamma) enzyme-linked immunospot assay using 3 recombinant HCV p

153 eens of immunized mice by a gamma interferon enzyme-linked immunospot assay using peptides derived fr

154 Proliferation and gamma interferon enzyme-linked immunospot assays using peripheral blood l

155 s-specific CD4 responses by gamma interferon enzyme-linked immunospot assay, using 410 overlapping pe

156 An interferon-gamma enzyme-linked immunospot assay, using peptide pools span

157 ic T cells were measured by interferon-gamma enzyme-linked immunospot assays, using recombinant vacci

158 gamma interferon-producing cells detected by enzyme-linked immunospot assay was increased (P < 0.01 f

159 Enzyme-linked immunospot assay was used for detecting AN

160 An IFN-gamma enzyme-linked immunospot assay was used to determine the

161 assay and/or ex vivo interferon (IFN)-gamma enzyme-linked immunospot assay, was documented in 45.5%

162 Using enzyme-linked immunospot assay we found higher frequenci

163 Using an enzyme-linked immunospot assay, we evaluated immunoglobu

164 Using flow cytometric analysis and enzyme-linked immunospot assay, we examined peripheral n

165 etanus immunoglobulin G levels based on LLPC enzyme-linked immunospot assay, we were unable to fit th

166 Mycoplasma pneumoniae ASCs measured by enzyme-linked immunospot assay were assessed alongside M

167 asured by gamma interferon and interleukin 2 enzyme-linked immunospot assay were significantly higher

168 Interferon gamma (IFN-gamma) enzyme-linked immunospot assays were performed before an

169 Enzyme-linked immunospot assays were performed to confir

170 a interferon-secreting cells, as detected by enzyme-linked immunospot assay, were obtained in respons

171 cing CD4(+) T cell responses, as assessed by enzyme-linked immunospot assay, were significantly more

172 )-4-secreting cells were determined using an enzyme-linked immunospot assay, which demonstrated that

173 MPO-specific T cells were quantified by enzyme-linked immunospot assay with additional Treg cell

174 Enzyme-Linked ImmunoSpot assays yielded parallel results